CSW-1

N/A

Report date: 2022/02/21 10:34:42

Base Information

Drug NameCSW-1
Drug Alias NameCSW-1
ClassificationBiologics
Mechanisms of ActionEnvelope glycoprotein gp160 inhibitors
TargetsEnvelope glycoprotein gp160
Therapy Area/IndicationsCoronavirus InfectionsSevere Acute Respiratory Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesTulane University School Of MedicineAutoimmune Technologies Llc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAutoimmune Technologies LlcTulane University School Of Medicine
Active IndicationsN/A
Inactive IndicationsCoronavirus InfectionsSevere Acute Respiratory Syndrome

Other Information

ATC CodeN/A
Related LinksN/A